Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
复制标题
DOI:
10.1016/j.tube.2016.09.004
复制
发表时间:
2016-12
期刊:
影响因子:
--
通讯作者:
Dennis M
中科院分区:
文献类型:
--
作者:
Sharpe S;White A;Sarfas C;Sibley L;Gleeson F;McIntyre A;Basaraba R;Clark S;Hall G;Rayner E;Williams A;Marsh PD;Dennis M
Intradermal (ID) BCG injection provides incomplete protection against TB in humans and experimental models. Alternative BCG vaccination strategies may improve protection in model species, including rhesus macaques. This study compares the immunogenicity and efficacy of BCG administered by ID and intravenous (IV) injection, or as an intratracheal mucosal boost (ID + IT), against aerosol challenge with Mycobacterium tuberculosis Erdman strain. Disease pathology was significantly reduced, and survival improved, by each BCG vaccination strategy, relative to unvaccinated animals. However, IV induced protection surpassed that achieved by all other routes, providing an opportunity to explore protective immunological mechanisms using antigen-specific IFN-γ ELISpot and polychromatic flow cytometry assays. IFN-γ spot forming units and multifunctional CD4 T-cell frequencies increased significantly following each vaccination regimen and were greatest following IV immunisation. Vaccine-induced multifunctional CD4 T-cells producing IFN-γ and TNF-α were associated with reduced disease pathology following subsequent M.tb challenge; however, high frequencies of this population following M.tb infection correlated with increased pathology. Cytokine producing T-cells primarily occupied the CD4 transitional effector memory phenotype, implicating this population as central to the mycobacterial response, potentially contributing to the stringent control observed in IV vaccinated animals. This study demonstrates the protective efficacy of IV BCG vaccination in rhesus macaques, offering a valuable tool for the interrogation of immunological mechanisms and potential correlates of protection.
登录
查看更多内容
影响因子:
--
作者:
Aguilo, Nacho;Toledo, Ana Maria;Martin, Carlos
通讯作者:
Martin, Carlos
DOI:
10.4049/jimmunol.1101122
发表时间:
2011-09-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Day CL;Abrahams DA;Lerumo L;Janse van Rensburg E;Stone L;O'rie T;Pienaar B;de Kock M;Kaplan G;Mahomed H;Dheda K;Hanekom WA
通讯作者:
Hanekom WA
DOI:
10.1017/s0022172400041851
发表时间:
1969-01-01
期刊:
JOURNAL OF HYGIENE-CAMBRIDGE
影响因子:
--
作者:
DRUETT, HA
通讯作者:
DRUETT, HA
DOI:
10.1164/rccm.201003-0334oc
发表时间:
2010-10-15
影响因子:
24.7
作者:
Kagina, Benjamin M. N.;Abel, Brian;Hanekom, Willem A.
通讯作者:
Hanekom, Willem A.
影响因子:
3.1
作者:
Chackerian, AA;Perera, TV;Behar, SM
通讯作者:
Behar, SM